Global Academic and Non-Profit Partnering Terms and Agreements 2016-2023

$3,995.00

Global Academic and Non-Profit Partnering Terms and Agreements 2016 to 2023 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. 

Publication date
March 2023
Number of pages
3400+
Product type
Research report
Available formats
PDF document
Report edition
3
SKU
CP1011

Global Academic and Non-Profit Partnering Terms and Agreements 2016 to 2023 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

 

This report provides details of the latest Academic and Non-Profit agreements announced in the life sciences since 2016.

 

The report takes the reader through a comprehensive review Academic and Non-Profit deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Academic and Non-Profit partnering deals.

 

The report presents financial deal term values for Academic and Non-Profit deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

 

The middle section of the report explores the leading dealmakers in the Academic and Non-Profit partnering field; both the leading deal values and most active Academic and Non-Profit dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

 

One of the key highlights of the report is that over 5,000 online deal records of actual Academic and Non-Profit deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

 

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

 

The initial chapters of this report provide an orientation of Academic and Non-Profit dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Academic and Non-Profit dealmaking since 2016, including details of headline, upfront, milestone and royalty terms.

 

Chapter 3 provides a review of the leading Academic and Non-Profit deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

 

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Academic and Non-Profit dealmaking with a brief summary followed by a comprehensive listing of Academic and Non-Profit deals announded by that company, as well as contract documents, where available.

 

Chapter 5 provides a comprehensive and detailed review of Academic and Non-Profit partnering deals signed and announced since Jan 2016, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

 

Chapter 6 provides a comprehensive and detailed review of Academic and Non-Profit partnering deals signed and announced since Jan 2016. The chapter is organized by specific technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

 

A comprehensive series of appendices is provided organized by Academic and Non-Profit partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

 

The report also includes numerous tables and figures that illustrate the trends and activities in Academic and Non-Profit partnering and dealmaking since 2016.

 

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Academic and Non-Profit technologies and products.

 

Key benefits

 

Global Academic and Non-Profit Partnering Terms and Agreements 2016 to 2023 provides the reader with the following key benefits:

 

  • In-depth understanding of Academic and Non-Profit deal trends since 2016
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Academic and Non-Profit contracts entered into by leading biopharma companies
  • Identify most active Academic and Non-Profit dealmakers since 2016
  • Insight into terms included in a Academic and Non-Profit partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

 

Report scope

 

Global Academic and Non-Profit Partnering Terms and Agreements 2016 to 2023 is intended to provide the reader with an in-depth understanding and access to Academic and Non-Profit trends and structure of deals entered into by leading companies worldwide.

 

Academic and Non-Profit Partnering Terms and Agreements includes:

 

  • Trends in Academic and Non-Profit dealmaking in the biopharma industry since 2016
  • Access to headline, upfront, milestone and royalty data
  • Access to Academic and Non-Profit contract documents
  • Leading Academic and Non-Profit deals by value since 2016
  • Most active Academic and Non-Profit dealmakers since 2016

 

In Global Academic and Non-Profit Partnering Terms and Agreements 2016 to 2023, the available deals are listed by:

 

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type

 

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

The Global Academic and Non-Profit Partnering Terms and Agreements 2016 to 2023 report provides comprehensive access to available deals and contract documents for over 5,400 Academic and Non-Profit deals.

 

Analyzing actual contract agreements allows assessment of the following:

 

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Academic and Non-Profit Partnering Terms and Agreements 2016 to 2023 provides the reader with the following key benefits:

 

  • In-depth understanding of Academic and Non-Profit deal trends since 2016
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Academic and Non-Profit contracts entered into by leading biopharma companies
  • Identify most active Academic and Non-Profit dealmakers since 2016
  • Insight into terms included in a Academic and Non-Profit partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in Academic and Non-Profit dealmaking

 

2.1. Introduction

2.2. Academic and Non-Profit partnering over the years

2.3. Most active Academic and Non-Profit dealmakers

2.4. Academic and Non-Profit partnering by deal type

2.5. Academic and Non-Profit partnering by therapy area

2.6. Academic and Non-Profit partnering by technology type

2.7. Deal terms for Academic and Non-Profit partnering

2.7.1 Academic and Non-Profit partnering headline values

2.7.2 Academic and Non-Profit deal upfront payments

2.7.3 Academic and Non-Profit deal milestone payments

2.7.4 Academic and Non-Profit royalty rates

 

Chapter 3 – Leading Academic and Non-Profit deals

 

3.1. Introduction

3.2. Top Academic and Non-Profit deals by value

 

Chapter 4 – Most active Academic and Non-Profit dealmakers

 

4.1. Introduction

4.2. Most active Academic and Non-Profit dealmakers

4.3. Most active Academic and Non-Profit partnering company profiles

 

Chapter 5 – Academic and Non-Profit contracts dealmaking directory

 

5.1. Introduction

5.2. Academic and Non-Profit contracts dealmaking directory

 

Chapter 6 – Academic and Non-Profit dealmaking by technology type

 

Appendices

 

Appendix 1 – Academic and Non-Profit deals by company A-Z

Appendix 2 – Academic and Non-Profit deals by stage of development

Appendix 3 – Academic and Non-Profit deals by deal type

Appendix 4 – Academic and Non-Profit deals by therapy area

Appendix 5 – Deal type definitions

Appendix 6 – Further reading

 

About Wildwood Ventures

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Academic and Non-Profit partnering since 2016

Figure 2: Active Academic and Non-Profit dealmaking activity since 2016

Figure 3: Academic and Non-Profit partnering by deal type since 2016

Figure 4: Academic and Non-Profit partnering by disease type since 2016

Figure 5: Academic and Non-Profit partnering by technology type since 2016

Figure 6: Academic and Non-Profit deals with a headline value

Figure 7: Academic and Non-Profit deals with an upfront value

Figure 8: Academic and Non-Profit deals with a milestone value

Figure 9: Academic and Non-Profit deals with a royalty rate value

Figure 10: Top Academic and Non-Profit deals by value since 2016

Figure 11: Most active Academic and Non-Profit dealmakers since 2016

Pricing options

 

  • $3,995: single-user
  • $5,745: multi-user
  • $10,995: single site license
  • $17,995: global site license

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1CellBiO, 2bPrecise, 2cureX, 3B Pharmaceuticals, 3M, 3P Biopharmaceuticals, 3rd People’s Hospital of Shenzhen, 3Scan, 4D Molecular Therapeutics, 4D Path, 4D Pharma, 4P-Pharma, 7 Hills Pharma, 9 Meters Biopharma, 10X Genomics, 22nd Century, 23andMe, 180 Life Sciences, 221b Foundation, 908 Devices, A*STAR Agency for Science, Technology and Research, A*STAR Bioinformatics Institute, A*STAR Bioprocessing Technology Institute, A*STAR Genome Institute of Singapore, A*STAR Singapore Immunology Network, A*STAR’ Institute of Molecular and Cell Biology, A-Alpha Bio, Aachen University, AA Medical, Aarhus University, Aarhus University Hospital, AARP Healthcare, AavantiBio, Abaxis, Abbott Laboratories, Abbvie, Abby Grace Foundation, Abcam, AbCellera Biologics, Abeome, Abeona Therapeutics, Abera Bioscience, AbFero Pharmaceuticals, Abintus Bio, ABL Bio, Ablexis, Abpro, Abramson Cancer Center, Absolute Antibody, ABT Innovations, Abu Dhabi Stem Cells Center, ABVC BioPharma, ABX, Abzena, Academia Sinica, Academic Drug Discovery Consortium, Academic Medical Center, Academy of Military Medical Sciences (China), Academy of Nutrition and Dietetics, ACADIA Pharmaceuticals, AC Bioscience, Accelerate Brain Cancer Cure, Accelerated Cure Project for MS, Accelerator for Technological Research in Genomic Therapies, Acceliant, Accenture, AccuGenomics, Accumulus Synergy, Accuray, ACEA Biosciences, Acelrx Pharmaceuticals, Acer Therapeutics, Acerus, Achaogen, Ache, Achieve Life Science, Achilles Therapeutics, Acibadem University, AC Immune, Aclipse Therapeutics, ACMG Foundation for Genetic and Genomic Medicine, Actelion, Actimed Therapeutics, Actinium Pharmaceuticals, Actuate Therapeutics, Acucela, AcuraStem, AcureX Therapeutics, Acurx Pharmaceuticals, Adagene, Adamis Pharmaceuticals, Adaptimmune, Adaptive Phage Therapeutics, AdaptVac, Addario Lung Cancer Medical Institute, Addex Therapeutics, Addiction Institute of Mount Sinai, Adhera Therapeutics, Adial Pharmaceuticals, Adimab, ADInstruments, Aditx Therapeutics, adMare BioInnovations, Adnab, Aduro BioTech, Advaite, AdvaMed, Advanced Accelerator Applications, Advanced BioInformatics, Advanced BioNutrition, Advanced Clinical Trial Solutions, Advanced Neural Dynamics, Advanced Nuclear Medicine Ingredients, Advanced Regenerative Manufacturing Institute, Advaxis, AdventHealth, Advent International, Adventist Health, Aelan Cell Technologies, Aerogen, Aethon Therapeutics, Aetion, Aevi Genomic Medicine, Aevitas Therapeutics, Affigen, Affinia Therapeutics, Affinity Biosciences, Africa Centres for Disease Control and Prevention, Africa Medical Supplies Platform, Africa Union, AFYX Therapeutics, Age Labs, Agencja Badan Medycznych, Agendia, AgeneBio, AgeX Therapeutics, Agile Biodetection, Agilent Technologies, Agilis Biotherapeutics, Agilvax, Agriplex Genomics, AgroSource, AHN Autoimmunity Institute, AIBody, Aichi Medical University, AIDS Foundation of Chicago, Aiforia Technologies, AIG Hospitals, AIkido Pharma, Aileron Therapeutics, AI Longevity, AimedBio, AIM ImmunoTech, Aitbiotech, Aitrics, AiVita Biomedical, Ajinomoto Bio-Pharma Services, Ajou University Medical Center, AKC Canine Health Foundation, Akili Interactive Labs, AKL Research and Development, Akome Biotech, Akonni Biosystems, Akouos, Akoya Biosciences, Akrevia Therapeutics, Akriveia Therapeutics, Akston Biosciences, Albany Medical College, Albany Molecular Research, Alberta Cell Therapy Manufacturing, Alberta Health Services, Albert Einstein College of Medicine, Albert Einstein Healthcare Network, ALBOT Technologies, Albumedix, Alcami, Aldevron, Aleris, Aleta Biotherapeutics, Alexandria Venture Investments, Alexion Pharmaceuticals, Alex’s Lemonade Stand Foundation, Alfred E. Mann Institute for Biomedical Engineering, Algernon Pharmaceuticals, Align Technology, Aligos Therapeutics, Alimera Sciences, AliveCor, Alkahest, Alkemist Labs, Alkermes, ALK Positive, Allakos, AllCells, Allcure Kangtai Proton Technology, Allegheny General Hospital, Allegheny Technologies, Allelica, Allen Institute for Brain Science, Allergan, AllerGenis, AlleyCorp, Alliance for a Cavity-Free Future, Alliance For Cancer Care, Alliance for Cancer Gene Therapy, Alliance For Clinical Trials In Oncology, Alliance for Lupus Research, Alliance for Regenerative Medicine, Alligator Bioscience, Allogene Therapeutics, AlloSource, AlloVir, Allscripts, AllStripes, Almac Diagnostics, Almac Group, Almirall, Alnylam Pharmaceuticals, ALPHA10X, Alphamab Biopharmaceuticals, Alpha Tau Medical, ALR Technologies, ALS Association, ALS Finding a Cure Foundation, Alterity Therapeutics, Altimmune, Altoida, Altor BioScience, Altos Labs, ALTuCELL, Aluna, Alvarado Hospital Medical Center, ALX Oncology, Alzamend Neuro, Alzeca Biosciences, Alzecure Foundation, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Alzheimer's Foundation of America, Alzheimer's Research UK, Alzheimer Society Research, Alzheon, Amag Pharmaceuticals, Amal Therapeutics, Amarna Therapeutics, Amazon Web Services, Ambiopharm, Ambry Genetics, Amedisys, Amend Surgical, American Academy of Implant Dentistry Foundation, American Academy of Neurology, American Academy of Ophthalmology, American Academy of Orthopaedic Surgeons, American Academy of Pediatrics, American Animal Hospital Association, American Association for Cancer Research, American Association for the Study of Liver Diseases, American Association of Neuromuscular & Electrodiagnostic Medicine, American Brain Tumor Association, American Cancer Society, American College of Cardiology, American College of Chest Physicians, American College of Surgeons, American Dental Association, American Diabetes Association, American Foundation for AIDS Research (amfAR), American Gene Technologies, American Heart Association, American Liver Foundation, American Lung Association, American Medical Association, American Migraine Foundation, American National Multiple Sclerosis Society, American Physiological Society, American Skin Association, American Sleep Apnea Association, American Society for Aesthetic Plastic Surgery, American Society of Clinical Oncology (ASCO), American Society of Gene and Cell Therapy, American Society of Hematology, American Speech-Language-Hearing Association, American Type Culture Collection (ATCC), American Urological Association, American Veterinary Medical Foundation, AmerisourceBergen, Ametek, Amfora, Amgen, Amicus Therapeutics, Amneal Pharmaceuticals, Amnion Foundation, AMPEL BioSolutions, Ampio Pharmaceuticals, Amplifybio, AmpliPhi Biosciences, AMR, AMRA Medical, Amryt Pharma, Amydis, Amygdala Neurosciences, Amylyx Pharmaceuticals, Amyris, Amytrx Therapeutics, Anahit, Analytical Biological Services, AnaMar, ANANDA Scientific, AnchorDx, Ancilia Biosciences, Andelyn Biosciences, Anew Medical, Angany, Angers University, Angiogenesis Foundation, Angiostem, Angle, Angsana Molecular & Diagnostics, Anhalt University of Applied Sciences, Anika Therapeutics, Anixa Biosciences, Anji Pharma, Anju Software, Ankyra Therapeutics, Anova Enterprises, Anpac Bio-Medical Science, ANP Technologies, Antabio, Antaros Medical, Antengene, Anthem, Anthony Nolan, Antibiotic Research UK, AntibioTx, Antidote, Antidote Therapeutics, Antios Therapeutics, Antisoma Therapeutics, Anumana, AO Foundation, Apexigen, Aplastic Anemia & MDS International Foundation, Apollo Hospitals Group, Apollo Sugar, Apollo Therapeutics, Appello Pharmaceuticals, Appili Therapeutics, Appistry, Applied Biology, Applied Cells, Applied DNA Sciences, Applied Genetic Technologies, Applied Pharmaceutical Innovation, Applied Therapeutics, AppliedVR, Aprea, Aprecia Pharmaceuticals, APRINOIA Therapeutics, Aptahem, Aptamer Therapeutics, Aptinyx, Aptorum Group, Aptuit, Aquinnah Pharmaceuticals, Aquitaine Science Transfert (SATT Aquitaine), Aragen Bioscience, Aravive Biologics, Arbutus, ARCA Biopharma, Arch Biopartners, ARCH Personalized Medicine Initiative, Arctic Therapeutics, Arctic University of Norway, Arctic Vision, Arctoris, Arcturus Therapeutics, Arecor, Ares Genetics, Areva Med, Argonaut Manufacturing Services, Argonne National Laboratory, Ariadne Genomics, Aridis Pharmaceuticals, Arima Genomics, Arix Bioscience, Arizona State University, Arkansas Children's Research Institute, Arkansas Childrens Hospital, Ark Biosciences, ARK Crystal, ArmaGen, AroCell, Arrakis Therapeutics, Array Biopharma, Arrevus, Arsanis Biosciences, Artelo Biosciences, ArtemiLife, Artes Biotechnology, Artidis, Artios Pharma, Artiria Medical, Artizan Biosciences, Aruvant Sciences, Arzeda, Asan Medical Center, Asceneuron, Ascenion, Ascensia Diabetes Care, Ascentage Pharma, ASC Therapeutics, Asensus Surgical, Asep Medical, Ashion Analytics, ASH Research Collaborative, Ashvattha Therapeutics, Asia-Pacific Hepatocellular Carcinoma Trials Group, Asia Green Biotechnology, Asian Eye Institute, Asklepios Biopharmaceutical, Aslan Pharma, Aspect Biosystems, ASPiRA Labs, Assembly Biosciences, Assistance Publique-Hôpitaux de Paris, Association for Frontotemporal Degeneration, Association for the Advancement of Blood & Biotherapies, Association of Clinical Research Professionals, Associazione Poic e Dintorni APS, Assuta Medical Centers, Astarte Medical, Astellas Pharma, Asterias Biotherapeutics, Astex Pharmaceuticals, Asthma UK, AstraZeneca, Astute Medical, Asylia Therapeutics, Asys, ATAI Life Sciences, Atara Biotherapeutics, Atelerix, Athenex, Athos Therapeutics, Atomo Diagnostics, Atomwise, ATP, Atreca, Attune Medical, ATUM, Atvio Biotech, aTyr Pharma, Auburn University, Audaire Health, Audax Medical, Audentes Therapeutics, Audere, AUM Biosciences, AUM Biotech, AUM LifeTech, Aural Analytics, AuraVax Therapeutics, Auris Medical, Aurobindo Pharma, Aurora BioPharma, Aurora Cannabis, Aurum Ventures, AusHealth, Australasian Gastro Intestinal Research Foundation, Australian Department of Health and Ageing, Australian Foundation for Diabetes Research, Australian Medical Research Institute, Australian Research Council, Australian Research Data Commons, Autifony Therapeutics, Autism Speaks, Autobahn Labs, Autodesk, Autolus, Avacta, Avalon GloboCare, Avatamed, Avectas, Avellino Labs, Avera McKennan, Avery Therapeutics, Aveta Biomics, Aviana Molecular Technologies, Avicanna, Aviceda Therapeutics, Avidea Technologies, Avidity Biosciences, Aviragen Therapeutics, Avista Pharma Solutions, Avita Therapeutics, AVM Biotechnology, Avon Foundation, AVRA Surgical, Avrobio, Awair, Awakn Life Sciences, Axelys, Axial Biotherapeutics, AXIM Biotechnologies, Axiom Real-Time Metrics, Axonics Modulation Technologies, AxoSim, Axovant Gene Therapies, Axsome Therapeutics, Azitra, AZUSA Pacific University, Babraham Bioscience Technologies, Babraham Institute, Babson Diagnostics, Bacit, Baebies, Bank of America, Banner MD Anderson Cancer Center, Baptist Health Care, Barbara Ann Karmanos Cancer Institute, Barer Institute, Barrow Neurological Institute, Barth Syndrome Foundation, Baruch S Blumberg Institute, Bascom Palmer Eye Institute, Baszucki Brain Research Fund, Batavia Biosciences, Bateman Horne Center, Battelle, Baudry Laboratory, Bausch & Lomb, Bausch Health Companies, Bavarian Brewing & Beverage Institute, Bavarian Nordic, Baxter International, Bay Area Lyme Foundation, Bayer, Bayer CropScience, Baylor College, Baylor College of Medicine, Baylor Genetics, Baylor Health Care System, Baylor Scott and White Research Institute, BCD Bioscience, BC Neuroimmunology, BC Platforms, Beactica, Beam Therapeutics, Beckman Coulter, Beckman Research Institute of City of Hope, Becton Dickinson, Beijing Illness Challenge Foundation, Beijing University of Chinese Medicine, Belgian Society of Medical Oncology, Bellicum Pharmaceuticals, Bellus Health, Ben-Gurion University, Benaroya Research Institute, BenevolentAI, Benjamin Rose Institute on Aging, Berg, Berkeley Lights, Beroni Group, Beryl Institute, Best Medical International, Beth Israel Deaconess Medical Center, BetterLife Pharma, Better Therapeutics, Beyond Air, Beyond Batten Disease Foundation, Beyond Cancer, Beyondspring Pharmaceuticals, Beyond Type 1, BGI, BGN Technologies, Bharat Biotech, BHB Therapeutics, BHVI, BIA Separations, BICO, Bicycle Therapeutics, Bill and Melinda Gates Foundation, Binex, Bio-Me, Bio-Path, Bio-Rad Laboratories, Bio-Techne, BioAesthetics, bioAffinity Technologies, BioAgilytix, BioArctic Neuroscience, BIOASTER, BioAxone Therapeutic, Biobeat, BioBridge Global, BioBright, BioCanna Healthcare, BioCanRx, Biocept, Biocodex Microbiota Foundation, Biocom Institute, BioComo, Biocon, BioCopy, Biodesix, Biodextris, BioDigital, BioEclipse Therapeutics, Biofabri, Bio Farma, Biofourmis, Biogen, Biohaven Pharmaceuticals, BioIntelliSense, BioInvent, BioLabs, Biolase, BioLegend, BIOLIFE4D, BiolineRX, BioLink Life Sciences, Biolog-id, Biological Dynamics, Biological Industries, BiologIC Technologies, Biomanufacturing Training and Education Center, Biomarck Pharmaceuticals, BioMarin Pharmaceutical, BioMark Diagnostics, BioMarker Strategies, BioMatrix Specialty Pharmacy, BiomeBank, Biomed, Biomedical Advanced Research and Development Authority, Biomedical Catalyst Fund (UK), BioMed Realty Trust, BioMed X Innovation Center, Biomerica, Biomerics, bioMerieux, Biomica, Biomodex, BiomX, BiondVax, Bionik Laboratories, Bionovus Life Sciences, BioNTech, BioOhio, Bio Palette, BiopharmX, BioPontis Alliance, BioReference Laboratories, BioRestorative Therapies, Biosenta, Bioserve, BioSight, BioSig Technologies, BioSilta, BioSkryb, Biostage, Biosynth, BioTechnique, Biotechnology and Biological Sciences Research Council (BBSRC), Biotechnology Industry Research Assistance Council, BioTheryX, Biotricity, BioVaxys, Bioventus, Biovo Technologies, BioXcel, Bird Foundation, Blackfynn, Blackrock Neurotech, BlackThorn Therapeutics, Bleeding Disorders Foundation, BlinkBio, Blood Systems Research Institute, Bloom Medicinals, Bloom Science, Blu Biotech, Blueberries Medical, Bluebird Bio, Blue Buffalo Company, Blue Cross Blue Shield Association, Blue Earth Diagnostics, Bluefield Innovations, Blue Note Therapeutics, BluePen Biomarkers, Blueprint Genetics, Blueprint Medicines, BlueRock Therapeutics, Blue Water Vaccines, Blum Center for Health, Blumentech, Body Labs, Boehringer Ingelheim, Bohai Biomedical, Bolder BioTechnology, Bold Therapeutics, Bone Biologics, Bonnie J. Addario Lung Cancer Foundation, Bon Secours Health System, Boomer Esiason Foundation, Booz Allen, Boragen, Boston Biomedical, BostonGene, Boston Medical Center, Boston Scientific, BostonSight, Boston University, Boston University School of Medicine, Boulos and Cooper Pharmaceuticals, Brain & Behavior Research Foundation, Brain Balance Achievement Centers, Brain Biomarker Solutions in Gothenburg, BRAINBox Solutions, BrainLAB, Brainomix, Brain Research Through Advancing Innovative NeurotechnologiesInitiative, Brain Science Foundation, BrainStorm Cell Therapeutics, Brain Trauma Foundation, Brain Treatment Center San Diego, Brandeis University, BRCA Foundation, Breast Cancer Research Foundation (BCRF), Breath Diagnostics, Breathtec BioMedical, BreathTech, BriaCell Therapeutics, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, BridGene Biosciences, Brigham and Women's Hospital, Brigham Young University, BrightFocus Foundation, Brightseed, Brii Biosciences, Brink Biologics, Bristol-Myers Squibb, Bristol-Myers Squibb Foundation, British Lung Foundation, British Pharmacological Society, Broad Institute, Brooks Automation, Brooks Rehabilitation, Brotman-Baty Institute, Brown University, Bruker, BryoLogyx, BTG, Buck Institute for Age Research, Bugworks, BullFrog AI, Bumrungrad International, Bunker Pflanzenextrakte, Burgerhospital, Burke Neurological Institute, Burnet Institute, Busan Paik Hospital, Butantan Institute, Butterfly Network, C-RAD, C2N Diagnostics, C4 Therapeutics, Cabaletta Bio, Cactus Semiconductor, Cadila Pharmaceuticals, Caelum Biosciences, Caerus Discovery, Caladrius Biosciences, Cala Health, Caldera Pharmaceuticals, Calidi Biotherapeutics, California College of Natural Medicine, California Institute for Biomedical Research, California Institute for Regenerative Medicine, California Institute of Technology, California Life Sciences Association, California Parkinson's Disease Registry, Calimmune, Calithera Biosciences, Calviri, Calyxt, Cambridge Brain Sciences, Cambridge Enterprise, Cambridge Epigenetix, Cambridge Research Biochemicals, Cam Med, Can-Fite BioPharma, Canada-Israel Industrial R&D Foundation, Canadian Cancer Society, Canadian Cancer Trials Group, Canadian Institutes of Health Research, Canadian Organization for Rare Disorders, Canaf Therapeutics, CANbridge Pharmaceuticals, Cancer Australia, CancerCare, Cancer Focus Fund, Cancer Hospital Chinese Academy of Medical Sciences, CancerLinQ, Cancer Molecular Diagnostic Laboratory, Cancer Prevention and Research Institute of Texas, Cancer Research Institute, Cancer Research Society, Cancer Research Technology, Cancer Research UK, Cancer Science Institute of Singapore, CancerVax, Candela, Candel Therapeutics, Cannex Scientific, Canntab Therapeutics, Canon BioMedical, Canopy Biosciences, Canopy Growth, Cantabio Pharmaceuticals, Cantex Pharmaceuticals, Capillary Biomedical, Capitainer, Capricor Therapeutics, Caprion Biosciences, Caprisa, Capsulomics, Caraway Therapeutics, CARB-X, Carbios, Carbiotix, Cardea Bio, Cardiff University, Cardiogen Sciences, Cardiomatics, Cardio Renal Society of America, Cardiovascular Research Foundation, Cardiovascular Systems, Cardiowise, Care4Rare Consortium, CareDox, CareDx, CareFirst BlueCross BlueShield, CareJourney, CarePoint Health, Carestream Health, Caribou Biosciences, CariCord, Carilion Clinic, Carina Biotech, Caris Life Sciences, Carisma Therapeutics, Carlsmed, Carl Zeiss, Carmentix, Carnegie Mellon University, CaroGen, Carolina BioOncology Institute, Carolinas Medical Center (CMC), Carrum Health, Carterra, CAS, Casebia Therapeutics, Case Western Reserve University, Case Western Reserve University School of Medicine, Casma Therapeutics, Castle Biosciences, Castle Creek Biosciences, Catabasis Pharmaceuticals, Catalent, Catamaran Bio, Catholic University Leuven, CavoGene LifeSciences, cbdMD, CB Therapeutics, CDISC, CDR-Life, Ceapro, Cedars-Sinai Health System, Cedars-Sinai Medical Center, CEITEC, Celcuity, Celdara Medical, Celgene, Celiac Disease Foundation, Cell and Gene Therapy Catapult, Cellares, Cellaria Biosciences, CellBion, Cellectar Biosciences, Cellect Biotechnology, Cellerant Therapeutics, Cellesce, Cellevolve Bio, Cellex, CELLINK, Cell Medica, Cell Mogrify, Cellpath, CellResearch, Cell Signaling Technology, Cell Therapy Catapult, Cell Therapy Manufacturing Center, Cellth Systems, Celltrion, Cellular Biomedicine, Cellular Dynamics International, Cellvation, Celonic, Cel Sci, Celsius Therapeutics, Celyad, Centene, Center for Aquaculture Technologies, Center for Biomarker Research in Medicine, Center for Breakthrough Medicines, Center for Cancer and Blood Disorders, Center for Contemporary Sciences, Center for Excellence in Engineering Biology, Center for Genomic Regulation, Center for Human Genetics and Laboratory Medicine, Center for Infectious Disease Research, Center for Inherited Blood Disorders, Center for International Blood and Marrow Transplant Research, Center for Molecular Medicine, Center for Sensorimotor Neural Engineering, Center for Structured Organic Particulate Systems, Center for the Advancement of Science in Space, Center on Addiction, Centers for Disease Control and Prevention, Centivax, Centogene, Central Institute for Experimental Animals, Centre for Addiction and Mental Health, Centre for Cellular and Molecular Platforms, Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Drug Research and Development (CDRD), Centre for Human Drug Research, Centre for Probe Development and Commercialization, Centre For Proteomic & Genomic Research, Centre for Structural Systems Biology, Centre For The Commercialization Of Antibodies And Biologics, Centre Hospitalier Universitaire Vaudois (CHUV), Centre Leon Berard, Centro de Inmunolgía Molecular, Centro de Investigación Biomédica en Red de Salud Mental, Centrus Health Clinics, Cepheid, Cerba HealthCare, Cerebain Biotech, Cerecor, CereScan, Cerevance, CERIMED, Certara, Certified Endoscopy, Certintell, Certis, Cerus, Cerveau Technologies, CFTechnology.org, ChadTough Foundation, Chamishi Therapeutics, Champalimaud Foundation, Champions Oncology, Chan Zuckerberg Initiative, Chao Center, Charak Foundation, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Charles River Associates, Charles River Laboratories, Charlotte's Web, CHDI Foundation, Checkpoint Therapeutics, Chembio Diagnostics, ChemDiv, ChemGenes, ChemImage, Chemomab Therapeutics, Children's Cancer Therapy Development Institute, Children's Heart Foundation, Children's Hospital at Montefiore, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Michigan Foundation, Children's Hospital of Philadelphia, Children's Hospital of Pittsburgh, Children's Hospital of Pittsburgh Foundation, Children's Hospital Of Wisconsin, Children's Medical Research Institute, Children's Mercy Hospital, Children's Minnesota, Children's National Health System, Children's National Hospital, Children's National Medical Center, Children's Research Institute, Children´s Oncology Group (COG), Children’s Center for Cancer and Blood Diseases (CCCBD), Children’s Hospital & Research Center Oakland, Children’s Hospital Oakland Research Institute (CHORI), Chimeric Therapeutics, Chimeron Bio, China Agricultural University, China Southeast University, Chinese Academy of Agricultural Science, Chinese Academy of Sciences, Chinese University of Hong Kong, Chinook Therapeutics, Cholangiocarcinoma Foundation, Chondrial Therapeutics, Chonnam National University, Christian Doppler Research Association, Christopher & Dana Reeve Foundation, Christus Health, Chromocell, Chubu University, Chugai Pharmaceutical, Chugai Pharma Marketing, Chung-Ang University, Chung Shan Medical University Hospital, CHU Sainte-Justine, Cidara Therapeutics, Cigna Healthcare, Ciitizen, Cincinnati Children’s Hospital Medical Center, Cinda Bio-Pharmaceutical, Cipla, Circuit Clinical, Circulogene, CISCRP, Citius Pharmaceuticals, Citizens United for Research in Epilepsy, Citranvi Biosciences, City College of New York, City of Hope, City of Hope Comprehensive Cancer Center, City University of New York Center for Advanced Technology, Civetta Therapeutics, Civica Rx, Clalit Health Fund, Claritas HealthTech, Clarus Therapeutics, Cleara Biotech, Clearbridge Biomedics, Clear Guide Medical, ClearLight Biotechnologies, ClearLight Diagnostics, Clearmind Medicine, ClearPath, Clene Nanomedicine, Cleveland Clinic, Cleveland Diabetes Care, Cleveland University Hospitals, CLEW Medical, ClinEdge, Clinical Development Services Agency, Clinical Genomics, Clinical Laserthermia Systems (CLS), Clinical Registry Investigating Bardet-Biedl Syndrome, ClinicalStudyDataRequest, Clinica Universidad Navarra, Clinton Health Access Initiative, Cloudera, Clover Biopharmaceuticals, CMT Research Foundation, CN Bio, CNS Pharmaceuticals, Co-Diagnostics, Coala Life, Coalition for Epidemic Preparedness Innovations, Coalition for the Advancement of Research and Innovation in Trauma, Coapt, CoapTech, Coave Therapeutics, Cobra Biologics, CoBTeK, Cochin Hospital, Cocrystal Pharma, CODA Biotherapeutics, Codagenix, Codetta Biosciences, Codex DNA, Codiak BioSciences, Coeptis Therapeutics, Cognition Therapeutics, Cognito Therapeutics, Cognoa, CogState, Cohen Veterans Bioscience, CoImmune, Colby College, Cold Spring Harbor, Colgate Palmolive, Colgate University, Collaborative Trajectory Analysis Project, Collplant, Colorado Center for Personalized Medicine, Colorado Melanoma Foundation, Colorado School of Mines, Colorado State University, Columbia Technology Ventures, Columbia University, Columbia University Medical Center, Combat Stress, Comet Biorefining, Commonwealth of Pennsylvania, Companhia Energetica Integrada, Compentex, Complutense University of Madrid, Compugen, Conagen, Concordia University, Concord Medical Services Holdings, Concr, Confluent Medical Technologies, ConforMIS, Congenica, ConserV Bioscience, ConsortiaTX, Contakt World Technologies, Context Therapeutics, Contextual Genomics, CONTINUUS Pharmaceuticals, ContraFect, ContraVir Pharmaceuticals, ConverGene, Cook Pharmica, Cooper Companies, COPD Foundation, Copenhagen University Hospital, Corbin Therapeutics, Core One Labs, Coretec Group, Corindus Vascular Robotics, Cornell University, Corpometria Institute, CorTechs Labs, Corteva Agriscience, Corvus Pharmaceuticals, COTA, Covalab, Covalon Technologies, Covar Pharmaceuticals, COVAX, COVAXX, Covenant Christian School, Coya Therapeutics, CPI International, Creative Destruction Lab, Creative Medical Technologies, Creoptix, Crescendo Biologics, Crescendo Bioscience, Crestone Pharma, Crestovo, Cricket Health, CRISPR Therapeutics, Critical Path Institute (C-Path), Crohn's and Colitis Foundation of America, Crown Bioscience, CRT Pioneer Fund, CSEM Centre Suisse d'Electronique et de Microtechnique, CSIR-Central Drug Research Institute, CSIR - Institute of Microbial Technology, CSIRO, CSL, CSL Behring, CSPC Pharmaceutical Group, Cubic, CUBRC, Cue Biopharma, Cullinan Oncology, Cultivar Holdings, Cumberland Emerging Technologies, Curable, Curadev Pharma, Curadigm, Curant Health, Curate Biosciences, Cure Alzheimer’s Fund, Cure AP-4, Curebase, CureCell, Cure Duchenne, Cure Network Dolby Acceleration Partners, CurePSP, Cure Sanfilippo Foundation, Cures Within Reach, Curetis, CureVac, Curing Kids Cancer, Current Health, CurveBeam AI, CV Sciences, Cybin, Cybrexa Therapeutics, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cyclica, Cyclolab, Cyclotek, Cyclo Therapeutics, CYduct Diagnostics, Cynapsus Therapeutics, Cypralis, Cyprium Therapeutics, Cyrus Biotechnology, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Cystic Fibrosis Trust, Cytecare Cancer Hospitals, Cytiva, CytoAgents, Cytocom, CytoImmune Therapeutics, Cytokinetics, CytoRecovery, CytoSen Therapeutics, Cytotheryx, Cytovation, CYTOVIA Therapeutics, Cytox, Cyxone, D&D Pharmatech, D. E. Shaw Research, Daewoong Pharmaceutical, Daiichi Sankyo, Dalberg, Dalhousie University, Dallas Lighthouse for the Blind, Dalton Pharma Services, Dana-Farber Cancer Institute, Dana Farber Partners Cancer Care, Danaher, Danish Cancer Society Research Center, Danish Center for Strategic Research into Type 2 Diabetes, Dante Labs, Dare Bioscience, DarioHealth, Dartmouth-Hitchcock Medical Center, Dartmouth College, Dassault Systems, Datavant, David H. Koch Institute for Integrative Cancer Research, DaVinci Biomedical Research Products, DaVita, Da Volterra, Day One Biopharmaceuticals, DayTwo, DCPrime, Deakin University, Deargen, Debiopharm, DEBRA Austria, Decathlon Capital Partners, Decibel Therapeutics, Deepcell, Deep Cube, Deep Science Ventures, Deerfield Management, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Defymed, DeGregorio Family Foundation, Deinove, Delcath Systems, Delfi Diagnostics, Dell Medical School, DelMar Pharmaceuticals, Delphi Diagnostics, DeMelle OncoPharma, Dementia Consortium, Demetrix, Denali Therapeutics, Denovo Biopharma, Densitas, Denso, Department of Defense, Department of Energy, Department of Health and Human Services, Department of Public Health, Department of Veterans Affairs, DermaPort, Dermelix Biotherapeutics, DermTech, Desktop Genetics, DevPro Biopharma, DexCom, Diabetes Research Connection, Diabetes Research Institute, Diabetes Singapore, DiaCarta, Diagnostic Robotics, Dialectic Therapeutics, DiamiR, Diamond Light Source, Diamond Therapeutics, Diamyd Medical, Diana Davis Spencer Foundation, Dianomi Therapeutics, Diaprost, Diffusion Pharmaceuticals, Digital Medicine Society, Digital Therapeutics Alliance, Dimension Therapeutics, DiNAQOR, Diomics, DiosCURE Therapeutics, DIOSynVax, Disability Solutions, DiscoveRx, DiscoveryBioMed, Distributed Bio, Diverse Biotech, Diversigen, Dixie State University, DNAnexus, DNA Script, DNAtrix, DoctorsOne Healthcare Systems, Domainex, Domain Therapeutics, Donald Danforth Plant Science Center, Dr. Reddy's Laboratories, Dr. Susan Love Research Foundation, Dragonfly Therapeutics, Dragon Master Foundation, Drake University, DreaMed Diabetes, Drexel University, DRI Capital, DrugDev, Drug Innovation Ventures at Emory, Drugs for Neglected Diseases Initiative, Duchenne UK, Duchesnay, Duke-NUS Graduate Medical School Singapore, Duke Cancer Institute, Duke Clinical Research Institute (DCRI), Duke University, Duke University Health System, Duke University Medical Center, DuPont, DuPont Industrial Biosciences, Duquesne University, Dutch SAZ, DWK Life Sciences, DxTerity, Dyadic International, DyNAbind, Dynavax Technologies, Dystonia Medical Research Foundation, Dystrophic Epidermolysis Bullosa Research Association of America, Dyve Biosciences, DZNE German Center for Neurodegenerative Diseases, E25Bio, Eagle Genomics, Eagle Pharmaceuticals, Eastern Michigan University, Eastern Ontario Regional Laboratory Association, Eberhard Karls University Tubingen, EB Research Foundation, EB Research Partnership, Eckerd College, Eclipse, ECM Therapeutics, ECOG-ACRIN Cancer Research Group, Ecole Polytechnique de Montreal, Ecole Polytechnique Federale de Lausanne, ECRI Institute, Edesa Biotech, Edico Genome, EdiGene, Edinburgh Innovations, Editas Medicine, Edith Wolfson Medical Center, Educational and Scientific, Edwards Lifesciences, eGenesis, EicOsis, Eiger BioPharmaceuticals, Eikonoklastes Therapeutics, Eisai, Eisai Inc, Eisai S.A.S, Eko, Elaaj Bio, Elanco, Elasmogen, Elastos Foundation, ElectroCore, Electromedical Technologies, Elekta, ElevateBio, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Elixirgen, Eloxx Pharmaceuticals, ElsaLys Biotech, Elsevier, Elute, Elysium Health, Embleema, Embryo Ventures, Emcure Pharmaceuticals, EMD Serono, Emendo Biotherapeutics, Emergency Medicine Foundation, Emergent BioSolutions, EmergeOrtho, Emergex Vaccines, Emirates Diabetes Society, EMMAC Life Sciences, Emocha Mobile Health, Emory Healthcare, Emory University, Emovi, Emtora Biosciences, Emulate, Enable Biosciences, Enamine, ENA Respiratory, EnBiotix, Endeavor BioMedicines, Endicott College, Endoluxe, Endomag, Endo Pharmaceuticals, Endotherm, Endpoint Health, ENDRA Life Sciences, Energy Medicine Research Institute, Enesi Pharma, Engrail Therapeutics, Enigma Biomedical, Enlivex, Enochian Biosciences, Enosis Therapeutics, Entasis Therapeutics, Enterin, Enterome Bioscience, Enterprise Ireland, Enterprise Therapeutics, Entos Pharmaceuticals, Entrada Therapeutics, Enumeral Biomedical, Enveric Biosciences, Envisagenics, EOFlow, EpicentRx, EpicGenetics, Epic Sciences, Epidemiologic Solutions, Epilepsy Canada, Epilepsy Foundation (EF), Epilepsy Society, EpimAb Biotherapeutics, Epinomics, Epiphany Dermatology, EpiPointe, Epistemic AI, Epivax, Epizyme, Epsilogen, Epygen Biotech, Equillium, Erasca, Erasmus University Medical Center, Erisyon, Erlangen University Hospital, ERS Genomics, ERT, Ervaxx, Erytech, Esophageal Cancer Awareness Association, EspeRare Foundation, Esperovax, Essent Biologics, Essen University Hospital, Eterna Therapeutics, eTheRNA immunotherapies, Ethris, ETH Zurich, Etubics, Eufloria Medical, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eureka Eurostars, Eureka Therapeutics, Eurofins Genomics, Eurofins Scientific, Eurofins Viracor, Euroimmun, European Biomedical Research Institute of Salerno, European Board and College of Obstetrics and Gynaecology, European Commission, European Laboratory for Particle Physics, European Laboratory Research & Innovation Group, European Molecular Biology Laboratory, European Organization for Research and Treatment of Cancer, European Society for Organ Transplantation, European Society for Radiotherapy & Oncology, European Union, European Union Regional Development Fund, European Vaccine Initiative, European Wellness Biomedical Group, EUSA Pharma, Evaxion Biotech, EV Biologics, Evecxia, Evelo Biosciences, Everest Medicines, Evergaze, Eversight, EverythingALS Open Innovation Consortium, EVerZom, Evestra, Evgen Pharma, Evidation Health, Evolus, Evolve BioSystems, Evonetix, EVOQ Therapeutics, Evotec, Evox Therapeutics, Ewha Womans University, Exacis Biotherapeutics, Exactis Innovation, Exact Sciences, Exact Therapeutics, Exagen Diagnostics, Exalenz Bioscience, ExcellGene, Excelra, Excision BioTherapeutics, Excivion, Exemplar Genetics, Exergen Medical, Exicure

For a full list contact us at orders@currentpartnering.com

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!